So far, clinical applications of CRISPR-based gene editing have been largely limited to editing a person's cells outside of their body and then ...
NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.
Morning Overview on MSN
One-time gene-editing treatment lowers LDL cholesterol in early trial
A single infusion of a CRISPR-based gene-editing therapy was associated with reductions in LDL cholesterol and triglycerides ...
Science Focus on MSN
How some people sleep only four hours a night and still feel great
A small group of humans barely rest at night – and never suffer for it. Science is about to find out why that matters for all ...
Editas Medicine announces USPTO reaffirms its prior decision in favour of the Broad Institute in CRISPR/Cas9 interference: Cambridge, Massachusetts Monday, March 30, 2026, 15:00 H ...
March 27 (Reuters) - A U.S. Patent Office tribunal has ruled against Nobel Prize-winning scientists Jennifer Doudna and Emmanuelle Charpentier for a second time in their dispute with the Broad ...
Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.
In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally evolved gene-editing system that can activate genes, offering an advantage ...
The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells engineered inside the human body, a mouse study has found. Cancer-fighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results